NSEDisclosure under SEBI Takeover Regulations19 Jun 2026 · 19 Jun 2026, 04:03 pm

Disclosure under SEBI Takeover Regulations

Aurobindo Pharma Limited · AUROPHARMA

✦ AI Summary

Aurobindo Pharma Limited has announced a disclosure under Regulation 31(4) of the SEBI Takeover Regulations. Promoter K. Nithyananda Reddy, on behalf of the promoter and promoter group, declared that they have not made any new encumbrances (such as pledges) on their shares in the company during the financial year ended March 31, 2026. This declaration confirms that no additional shares were pledged beyond what was already disclosed to the stock exchanges. For investors, this signifies transparency from the promoters regarding their shareholdings, providing reassurance about the stability of their stake.

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Aurobindo Pharma Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Attachments (1)

📄

team_bbodade_11052026184659_AUROPHARMA.pdf

pdf

Download →
View document text
Date: April7, 2026 To To Listing Department, The Corporate Relations Department NATIONAL STOCK EXCHANGE OF INDIA LIMITED SSE LIMITED Exchange Plaza, Phiroz Jeejeebhoy Towers, Bandra Kurla Complex, Bandra (E), 25th floor, Dalal Street, MUMBAI-400 051 MUMBAI-400 001 Company Code No. AUROPHARMA Company Code No. 524804 Dear Sir I Madam, Sub: Disclosure of encumbrance pursuant to Reg. 31(4) SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Pursuant to the applicable provisions of Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, I, K. Nithyananda Reddy, one of the Promoters of the Company and on behalf of the other promoter and Promoter Group of the Company hereby declare that we have not made any encumbrance, directlyor indirectly, on the shares held by us in Aurobindo Pharma Limited, other than those already disclosed to the Stock Exchanges during the financial year ended on March 31,2026. I am enclosing herewith the list of promoters and promoter group of Aurobindo Pharma Limited without PAN as on March 31, 2026 Please take the information on record. Thanking you, Yours faithfully, K. NITHYANANDA REDDY AUTHORISED SIGNATORY (PROMOTRS & PROMOTER GROUP-AUROBINDO PHARMA LIMITED) Plot No 75 and 76, Huda EncLave B, Nandagiri Hills Jubilee Hills, Shaikpet, Hyderabad -500033 AUROBINDO PHARMA LIMITED LIST OF PROMOTERS AND PROMOTER GROUP AS ON 31.03.2026 Sl. Name No. of shares % of the total No. held share capital 1 MR. VENKATA RAMPRASAD REDDY PENAKA 1,78,33,646 3.07 2 MR. KAMBAM NITYANANDA REDDY 2,53,59,572 4.37 3 DR.M SIVAKUMARAN 1,43,57,432 2.47 4 MRS. RAJESWARI KAMBAM 18,08,631 0.31 5 MRS.SUNEELA RANI PENAKA 1,28,799 0.02 6 MR.PRASADA REDDY KAMBHAM 2,98,373 0.05 7 MR. K SURYAPRAKASH REDDY 7,380 0.00 8 MR. M SUMANTH KUMAR REDDY 15,85,214 0.27 9 MRS. KIRTHI REDDY KAMBAM 2,00,62,852 3.45 10 MRS. K SPOORTHI 69,39,173 1.19 11 MRS.PENAKA NEHA REDDY - 0.00 12 TRIDENT CHEMPHAR LIMITED 7,82,241 0.13 13 AXIS CLiNICALS LIMITED 6,51,920 0.11 14 RPR SONS ADVISORS PRIVATE LIMITED, MRS.P.SUNEELA 19,45,61,357 33.50 RANI (JOINTLY HOLDING) 15 AXIS CLiNICALS LIMITED, TRIDENT CHEMPHAR LIMITED, 1,65,72,131 2.85 RPR SONS ADVISORS PVT. LTD. (JOINTLY HOLDING) Total 30,09,48,721 51.82